Qube Research & Technologies (QRT)
PRPH

Qube Research & Technologies (QRT)’s ProPhase Labs PRPH Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio PRPH Stock Details PRPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-3
Closed -$105 – 3937
2024
Q2 		$105 Hold
3
– – ﹤0.01% 3434
2024
Q1 		$162 Hold
3
– – ﹤0.01% 4153
2023
Q4 		$113 Hold
3
– – ﹤0.01% 4020
2023
Q3 		$109 Buy
+3
New +$176 ﹤0.01% 3759

Other funds holding PRPH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PCM
Perritt Capital Management Chicago, Illinois $59.8M AUM 26.94% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
CD
Chapin Davis Baltimore, Maryland $569M AUM 145.59% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Qube Research & Technologies (QRT)'s PRPH Position: Q3 2024 in Review

Qube Research & Technologies (QRT) sold out of ProPhase Labs (PRPH) in Q3 2024, closing a stake of 3 shares — an estimated $105 sold.

Qube Research & Technologies (QRT) first reported a position in PRPH in Q3 2023 and held it in 4 quarters. The position peaked at $162 in Q1 2024. 27 funds tracked by Wall St. Rank hold PRPH as of Q3 2024.

  • Qube Research & Technologies (QRT) reported no remaining ProPhase Labs position as of Q3 2024 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 3 ProPhase Labs shares in Q3 2024, an estimated $105.
  • Qube Research & Technologies (QRT) first reported a position in ProPhase Labs in Q3 2023 and held it in 4 quarters.
  • Qube Research & Technologies (QRT)'s ProPhase Labs position peaked at $162 in Q1 2024.
  • 27 funds tracked by Wall St. Rank held ProPhase Labs as of Q3 2024.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2024, filed 14 Nov 2024.